The role of 18F-FDG PET/CT in large-vessel vasculitis: Appropriateness of current classification criteria?

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Balink, H ^a   Bennink, R J ^b   Van Eck Smit, B L F ^b   Verberne, H J ^b  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHOTREXATE; PREDNISOLONE; PREDNISONE; RADIOPHARMACEUTICAL AGENT;

AORTA ARCH SYNDROME; AORTITIS; ARTERIAL WALL THICKENING; CLINICAL PRACTICE; COGAN SYNDROME; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; ECHOGRAPHY; EDEMA; FATALITY; HUMAN; LARGE VESSEL VASCULITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; RHEUMATIC POLYMYALGIA; TEMPORAL ARTERITIS; TEMPORAL ARTERY; VASCULITIS; CARDIOLOGY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PROCEDURES; RADIOLOGY; STANDARDS; UNITED STATES;

CARDIOLOGY; FLUORODEOXYGLUCOSE F18; HUMANS; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES AS TOPIC; RADIOLOGY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES; VASCULITIS;

EID: 84930649587     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/687608     Document Type: Review

References (111)

1. G. G. Hunder, W. P. Arend, D. A. Bloch et al., "The American College of Rheumatology 1990 criteria for the classifcation of vasculitis: introduction," Arthritis and Rheumatism, vol. 33, no. 8, pp. 1065-1067, 1990.
2. W. P. Arend, B. A. Michel, D. A. Bloch et al., "The American College of Rheumatology 1990 criteria for the classifcation of Takay a suarterit is," Arthritis and Rheumatism, vol. 33, no. 8, pp. 1129-1134, 1990.
3. G. G. Hunder, D. A. Bloch, B. A. Michel et al., "The American College of Rheumatology 1990 criteria for the classifcation of giant cell arteritis," Arthritis and Rheumatism, vol. 33, no. 8, pp. 1122-1128, 1990.
4. J. C. Jennette, R. J. Falk, K. Andrassy et al., "Nomenclature of systemic vasculitides: proposal of an international consensus conference," Arthritis and Rheumatism, vol. 37, no. 2, pp. 187-192, 1994.
5. J. C. Jennette, R. J. Falk, P. A. Bacon et al., "2012 revised international Chapel Hill consensus conference nomenclature of vasculitides," Arthritis & Rheumatology, vol. 65, no. 1, pp. 1-11, 2013.
6. S. S. Hayreh, P. A. Podhajsky, and B. Zimmerman, "Ocular manifestations of giant cell arteritis," American Journal of Ophthalmology, vol. 125, no. 4, pp. 509-520, 1998.
7. G. H. Hall, "Giant cell arteritis-an unholy trinity," The American Heart Journal, vol. 85, no. 6, pp. 835-837, 1973.
8. W. L. Gross, A. Trabandt, and E. Reinhold-Keller, "Diagnosis and evaluation of vasculitis," Rheumatology, vol. 39, no. 3, pp. 245-252, 2000.
9. D. Blockmans, S. Stroobants, A. Maes, and L. Mortelmans, "Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for infammation of the aortic arch," The American Journal of Medicine, vol. 108, no. 3, pp. 246-249, 2000.
10. D. Ernst, N. T. Baerlecken, R. E. Schmidt, and T. Witte, "Large vessel vasculitis and spondyloarthritis: coincidence or associated diseases?" Scandinavian Journal of Rheumatology, vol. 43, no. 3, pp. 246-248, 2014.
11. G. Liu, R. Shupak, and B. K. Y. Chiu, "Aortic dissection in giant-cell arteritis," Seminars in Arthritis and Rheumatism, vol. 25, no. 3, pp. 160-171, 1995.
12. G. M. Greene, D. Lain, R. M. Sherwin, J. E. Wilson, and B. M. McManus, "Giant cell arteritis of the legs. Clinical isolation of severe disease with gangrene and amputations," The American Journal of Medicine, vol. 81, no. 4, pp. 727-733, 1986.
13. R. G. Klein, G. G. Hunder, A. W. Stanson, and S. G. Sheps, "Large artery involvement in giant cell (temporal) arteritis," Annals of Internal Medicine, vol. 83, no. 6, pp. 806-812, 1975.
14. E. Nordborg and B.-A. Bengtsson, "Death rates and causes of death in 284 consecutive patients with giant cell arteritis confrmed by biopsy," British Medical Journal, vol. 299, no. 6698, pp. 549-550, 1989.
15. M. Hotchi, "Pathological studies on Takayasu arteritis," Heart and Vessels, vol. 7, no. 7, pp. 11-17, 1992.
16. H. L. Gornik and M. A. Creager, "Aortitis," Circulation, vol. 117, no. 23, pp. 3039-3051, 2008.
17. E. Y. Kissin and P. A. Merkel, "Diagnostic imaging in Takayasu arteritis," Current Opinion in Rheumatology, vol. 16, no. 1, pp. 31-37, 2004.
18. M. B. Gravanis, "Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors," International Journal of Cardiology, vol. 75, supplement 1, pp. S21-S33, 2000.
19. S. Unizony, L. Arias-Urdaneta, E. Miloslavsky et al., "Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica," Arthritis Care and Research, vol. 64, no. 11, pp. 1720-1729, 2012.
20. K. Maksimowicz-Mckinnon, T. M. Clark, and G. S. Hofman, "Takayasu arteritis and giant cell arteritis: a spectrum within the same disease?" Medicine, vol. 88, no. 4, pp. 221-226, 2009.
21. P. C. Grayson, K. Maksimowicz-McKinnon, T. M. Clark et al., "Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis," Annals of the Rheumatic Diseases, vol. 71, no. 8, pp. 1329-1334, 2012.
22. P. Seo and J. H. Stone, "Large-vessel vasculitis," Arthritis Care and Research, vol. 51, no. 1, pp. 128-139, 2004.
23. S. S. Hayreh, P. A. Podhajsky, R. Raman, and B. Zimmerman, "Giant cell arteritis: validity and reliability of various diagnostic criteria," The American Journal of Ophthalmology, vol. 123, no. 3, pp. 285-296, 1997.
24. A. Brack, V. Martinez-Taboada, A. Stanson, J. J. Goronzy, and C. M. Weyand, "Disease pattern in cranial and large-vessel giant cell arteritis," Arthritis & Rheumatology, vol. 42, no. 2, pp. 311-317, 1999.
25. H. Balink, R. J. Bennink, N. J. Veeger, B. L. van Eck-Smit, and H. J. Verberne, "Diagnostic utility of 18F-FDG PET/CT in infammation of unknown origin," Clinical Nuclear Medicine, vol. 39, no. 5, pp. 419-425, 2014.
26. C. Salvarani, F. Cantini, and G. G. Hunder, "Polymyalgia rheumatica and giant-cell arteritis," The Lancet, vol. 372, no. 9634, pp. 234-245, 2008.
27. J. M. Evans, W. M. O'Fallon, and G. G. Hunder, "Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study," Annals of Internal Medicine, vol. 122, no. 7, pp. 502-507, 1995.
28. B. Hamrin, N. Jonsson, and S. Hellsten, ""Polymyalgia arterit-ica". Further clinical and histopathological studies with a report of six autopsy cases," Annals of the Rheumatic Diseases, vol. 27, no. 5, pp. 397-405, 1968.
29. G. Ostberg, "On arteritis with special reference to polymyalgia arteritica," Acta Pathologica et Microbiologica Scandinavica, Supplement, vol. 237, pp. 1-59, 1973.
30. F. Rojo-Leyva, N. B. Ratlif, D. M. Cosgrove, and G. S. Hofman III, "Study of 52 patients with idiopathic aortitis from a cohort of 1, 204 surgical cases," Arthritis & Rheumatology, vol. 43, no. 4, pp. 901-907, 2000.
31. J. T. Lie, "Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation," Seminars in Arthritis and Rheumatism, vol. 24, no. 6, pp. 422-431, 1995.
32. T. Quéméneur, É. Hachulla, M. Lambert et al., "Takayasu arteritis," Presse Medicale, vol. 35, no. 5, pp. 847-856, 2006.
33. F. A. Weaver, S. R. Kumar, A. E. Yellin et al., "Renal revascu-larization in Takayasu arteritis-induced renal artery stenosis," Journal of Vascular Surgery, vol. 39, no. 4, pp. 749-757, 2004.
34. A. L. Bartels, C. J. Zeebregts, M. Bijl, R. A. Tio, and R. H. J. A. Slart, "Fused FDG-PET and MRI imaging of Takayasu arteritis in vertebral arteries," Annals of Nuclear Medicine, vol. 23, no. 8, pp. 753-756, 2009.
35. A. M. Goedhart-de Haan, S. J. Pans, K. D. Lensen, M. R. Meijerink, E. F. Comans, and Y. M. Smulders, "Vasculitis revealed by posterior stroke," Netherlands Journal of Medicine, vol. 70, no. 2, pp. 81-83, 2012.
36. B. Kaku, T. Higuchi, H. Kanaya et al., "Usefulness of fourine-18-fourodeoxyglucose positron emission tomography in a patient with Takayasu's arteritis associated with antiphospholipid syndrome," International Heart Journal, vol. 47, no. 2, pp. 311-317, 2006.
37. K. Miyagawa, J. Shiraishi, M. Nasu et al., "Usefulness of ultrasonography in carotid arteries and combined positron emission tomography/computed tomography for diagnosis of Takayasu arteritis with unusual presentation as acute myocar-dial infarction: a case report," Journal of Cardiology, vol. 50, no. 5, pp. 317-324, 2007.
38. A. N. Ezeonyeji, F. A. Borg, and B. Dasgupta, "Delays in recognition and management of giant cell arteritis: results from a retrospective audit," Clinical Rheumatology, vol. 30, no. 2, pp. 259-262, 2011.
39. C. Mukhtyar, L. Guillevin, M. C. Cid et al., "EULAR recommendations for the management of large vessel vasculitis," Annals of the Rheumatic Diseases, vol. 68, no. 3, pp. 318-323, 2009.
40. B. Dasgupta, "Concise guidance: diagnosis and management of giant cell arteritis," Clinical Medicine, vol. 10, no. 4, pp. 381-386, 2010.
41. K. Hamano, T. S. Li, M. Takahashi et al., "Enhanced tumor necrosis factor-α expression in small sized abdominal aortic aneurysms," World Journal of Surgery, vol. 27, no. 4, pp. 476-480, 2003.
42. M. Schirmer, C. Dufner, R. Seiler, C. Dejaco, and G. Fraedrich, "Abdominal aortic aneurysms: an underestimated type of immune-mediated large vessel arteritis?" Current Opinion in Rheumatology, vol. 18, no. 1, pp. 48-53, 2006.
43. D. M. Nuenninghof, G. G. Hunder, T. J. H. Christianson, R. L. McClelland, and E. L. Matteson, "Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and /or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years," Arthritis and Rheumatism, vol. 48, no. 12, pp. 3522-3531, 2003.
44. T. Belhocine, D. Blockmans, R. Hustinx, J. Vandevivere, and L. Mortelmans, "Imaging of large vessel vasculitis with 18FDG PET: illusion or reality? A critical review of the literature data," European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 9, pp. 1305-1313, 2003.
45. B. E. Schreiber, H. H. C. Tam, C. Carvalho, W. L. Wong, A. I. Russell, and C. S. Higgens, "F-18 PET-CT showing large vessel vasculitis in a patient with high infammatory markers and no localizing symptoms," Clinical Nuclear Medicine, vol. 34, no. 11, pp. 785-787, 2009.
46. K. D. F. Lensen, A. E. Voskuyl, C. J. van der Laken et al., "18F-Fluorodeoxyglucose positron emission tomography in elderly patients with an elevated erythrocyte sedimentation rate of unknown origin," PLoS ONE, vol. 8, no. 3, Article ID e58917, 2013.
47. S. Vanderschueren, E. Del Biondo, D. Ruttens, I. van Boxelaer, E. Wauters, and D. D. C. Knockaert, "Infammation of unknown origin versus fever of unknown origin: two of a kind," European Journal of Internal Medicine, vol. 20, no. 4, pp. 415-418, 2009.
48. H. Balink, J. Collins, G. A. Bruyn, and F. Gemmel, "F-18 FDG PET/CT in the diagnosis of fever of unknown origin," Clinical Nuclear Medicine, vol. 34, no. 12, pp. 862-868, 2009.
49. G. A. Hooisma, H. Balink, P. M. Houtman, R. H. J. A. Slart, and K. D. F. Lensen, "Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study," Clinical Rheumatology, vol. 31, no. 5, pp. 861-871, 2012.
50. J. F. Sheng, Z. K. Sheng, X. M. Shen et al., "Diagnostic value of fuorine-18 fuorodeoxyglucose positron emission tomography/computed tomography in patients with fever of unknown origin," European Journal of Internal Medicine, vol. 22, no. 1, pp. 112-116, 2011.
51. 18F-FDG-PET/CT with integrated full diagnostic isotropic CT imaging," European Journal of Radiology, vol. 73, no. 3, pp. 518-525, 2010.
52. 18F-FDG PET/CT," Journal of Nuclear Medicine, vol. 49, no. 12, pp. 1980-1985, 2008.
53. M. A. Walter, R. A. Melzer, C. Schindler, J. Müller-Brand, A. Tyndall, and E. U. Nitzsche, "The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease," European Journal of Nuclear Medicine and Molecular Imaging, vol. 32, no. 6, pp. 674-681, 2005.
54. K. Lee, A. Cho, Y. Choi et al., "The role of 18F-fuorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis," Arthritis and Rheumatism, vol. 64, no. 3, pp. 866-875, 2012.
55. M. Fuchs, M. Briel, T. Daikeler et al., "The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis," European Journal of Nuclear Medicine and Molecular Imaging, vol. 39, no. 2, pp. 344-353, 2012.
56. H. Hautzel, O. Sander, A. Heinzel, M. Schneider, and H. W. Müller, "Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutof ratio," Journal of Nuclear Medicine, vol. 49, no. 7, pp. 1107-1113, 2008.
57. M. Bruschi, F. de Leonardis, M. Govoni et al., "18FDG-PET and large vessel vasculitis: preliminary data on 25 patients," Reumatismo, vol. 60, no. 3, pp. 212-216, 2008.
58. L. Arnaud, J. Haroche, Z. Malek et al., "Is 18F-fuorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis?" Arthritis and Rheumatism, vol. 60, no. 4, pp. 1193-1200, 2009.
59. D. Blockmans, W. Coudyzer, S. Vanderschueren et al., "Relationship between fuorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis," Rheumatology, vol. 47, no. 8, pp. 1179-1184, 2008.
60. G. Treglia, M. V. Mattoli, L. Leccisotti, G. Ferraccioli, and A. Giordano, "Usefulness of whole-body fuorine-18-fuorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review," Clinical Rheumatology, vol. 30, no. 10, pp. 1265-1275, 2011.
61. P. Lehmann, S. Buchtala, N. Achajew et al., "18F-FDG PET as a diagnostic procedure in large vessel vasculitis-a controlled, blinded re-examination of routine PET scans," Clinical Rheumatology, vol. 30, no. 1, pp. 37-42, 2011.
62. H. Balink and G. A. W. Bruyn, "The role of PET/CT in Cogan's syndrome," Clinical Rheumatology, vol. 26, no. 12, pp. 2177-2179, 2007.
63. J. Andrews and J. C. Mason, "Takayasu's arteritis-recent advances in imaging ofer promise," Rheumatology, vol. 46, no. 1, pp. 6-15, 2007.
64. K. Ahmadi-Simab, B. Hellmich, K. Holl-Ulrich, C. Fleischmann, O. Dourvos, and W. L. Gross, "Acute coronary syndrome in Takayasu arteritis without elevation of acute phase parameters," Rheumatology, vol. 46, no. 3, pp. 554-555, 2007.
65. A. Toriihara, Y. Seto, K. Yoshida et al., "F-18 FDG PET/CT of polymyalgia rheumatica," Clinical Nuclear Medicine, vol. 34, no. 5, pp. 305-306, 2009.
66. H. Adams, P. Raijmakers, and Y. Smulders, "Polymyalgia rheumatica and interspinous FDG uptake on PET/CT," Clinical Nuclear Medicine, vol. 37, no. 5, pp. 502-505, 2012.
67. C. Salvarani, L. Barozzi, F. Cantini et al., "Cervical inter-spinous bursitis in active polymyalgia rheumatica," Annals of the Rheumatic Diseases, vol. 67, no. 6, pp. 758-761, 2008.
68. Y. Taniguchi, K. Arii, Y. Kumon et al., "Positron emission tomography/computed tomography: a clinical tool for evaluation of enthesitis in patients with spondyloarthritides," Rheumatology, vol. 49, no. 2, pp. 348-354, 2009.
69. Z. Rehak and P. Szturz, "Comment on: FDG PET in the early diagnosis of large-vessel vasculitis," European Journal of Nuclear Medicine and Molecular Imaging, vol. 41, no. 3, pp. 579-580, 2014.
70. F. Moosig, N. Czech, C. Mehl et al., "Correlation between 18-fuorodeoxyglucose accumulation in large vessels and serolog-ical markers of infammation in polymyalgia rheumatica: a quantitative PET study," Annals of the Rheumatic Diseases, vol. 63, no. 7, pp. 870-873, 2004.
71. M. Brodmann, R. W. Lipp, A. Passath, G. Seinost, E. Pabst, and E. Pilger, "The role of 2-18F-fuoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries," Rheumatology, vol. 43, no. 2, pp. 241-242, 2004.
72. K. Samejima, K. Nakatani, M. Sioyama et al., "Case of temporal arteritis: FDP-PET (18F-fuorodeoxyglucose-positron emission tomography) was useful for early diagnosis and treatment," Nihon Rinsho Meneki Gakkai Kaishi, vol. 33, no. 6, pp. 324-328, 2010.
73. S. P. Janssen, E. H. Comans, A. E. Voskuyl, W. Wisselink, and Y. M. Smulders, "Giant cell arteritis: heterogeneity in clinical presentation and imaging results," Journal of Vascular Surgery, vol. 48, no. 4, pp. 1025-1031, 2008.
74. M. Yun, S. Jang, A. Cucchiara, A. B. Newberg, and A. Alavi, "18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors," Seminars in Nuclear Medicine, vol. 32, no. 1, pp. 70-76, 2002.
75. T. Belhocine, D. Blockmans, R. Hustinx, J. Vandevivere, and L. Mortelmans, "Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data," European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 9, pp. 1305-1313, 2003.
76. H. Balink, P. M. Houtman, and J. Collins, "18F-FDG PET versus PET/CT as a diagnostic procedure for clinical suspicion of large vessel vasculitis," Clinical Rheumatology, vol. 30, no. 8, pp. 1139-1141, 2011.
77. M. P. Dunphy, A. Freiman, S. M. Larson, and H. W. Strauss, "Association of vascular 18F-FDG uptake with vascular calci-fcation," Journal of Nuclear Medicine, vol. 46, no. 8, pp. 1278-1284, 2005.
78. T. J. Reape and P. H. E. Groot, "Chemokines and atherosclerosis," Atherosclerosis, vol. 147, no. 2, pp. 213-225, 1999.
79. J. N. Wilcox and N. A. Scott, "Potential role of the adventitia in arteritis and atherosclerosis," International Journal of Cardiology, vol. 54, pp. S21-S35, 1996.
80. F. Numano, Y. Kishi, A. Tanaka, M. Ohkawara, T. Kakuta, and Y. Kobayashi, "Infammation and atherosclerosis: atherosclerotic lesions in Takayasu arteritis," Annals of the New York Academy of Sciences, vol. 902, pp. 65-76, 2000.
81. N. Tahara, H. Kai, S. Yamagishi et al., "Vascular infamma-tion evaluated by [18F]-fuorodeoxyglucose positron emission tomography is associated with the metabolic syndrome," Journal of the American College of Cardiology, vol. 49, no. 14, pp. 1533-1539, 2007.
82. A. P. Burke and R. Virmani, "Localized vasculitis," Seminars in Diagnostic Pathology, vol. 18, no. 1, pp. 59-66, 2001.
83. S. H. Morgan, R. A. Asherson, and G. R. V. Hughes, "Distal aortitis complicating Reiter's syndrome," British Heart Journal, vol. 52, no. 1, pp. 115-116, 1984.
84. V. Weiler, S. Redtenbacher, C. Bancher, M. B. Fischer, and J. S. Smolen, "Concurrence of sarcoidosis and aortitis: case report and review of the literature," Annals of the Rheumatic Diseases, vol. 59, no. 11, pp. 850-853, 2000.
85. B. F. Haynes, M. I. Kaiser-Kupfer, P. Mason, and A. S. Fauci, "Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature," Medicine, vol. 59, no. 6, pp. 426-441, 1980.
86. 18F-FDG PET/CT: syphilitic?" Clinical Rheumatology, vol. 32, no. 5, pp. 705-709, 2013.
87. K. Kösters, C. P. Bleeker-Rovers, R. van Crevel, W. J. G. Oyen, and A. J. A. M. van der Ven, "Aortitis diagnosed by F-18-fuorodeoxyglucose positron emission tomography in a patient with syphilis and HIV coinfection," Infection, vol. 33, no. 5-6, pp. 387-389, 2005.
88. G. Treglia, S. Taralli, F. Maggi, A. Coli, L. Lauriola, and A. Giordano, "Usefulness of 18F-FDG PET/CT in disease extent and treatment response assessment in a patient with syphilitic aortitis," Clinical Nuclear Medicine, vol. 38, no. 4, pp. e185-e187, 2013.
89. M. Kuwana, S. Wakino, T. Yoshida, and M. Homma, "Concise communication: retroperitoneal fbrosis associated with aorti-tis," Arthritis and Rheumatism, vol. 35, no. 10, pp. 1245-1247, 1992.
90. D. Blockmans, T. Bley, and W. Schmidt, "Imaging for large-vessel vasculitis," Current Opinion in Rheumatology, vol. 21, no. 1, pp. 19-28, 2009.
91. S. Förster, F. Tato, M. Weiss et al., "Patterns of extracranial involvement in newly diagnosed giant cell arteritis assessed by physical examination, colour coded duplex sonography and FDG-PET," Vasa, vol. 40, no. 3, pp. 219-227, 2011.
92. M. Both, K. Ahmadi-Simab, M. Reuter et al., "MRI and FDG-PET in the assessment of infammatory aortic arch syndrome in complicated courses of giant cell arteritis," Annals of the Rheumatic Diseases, vol. 67, no. 7, pp. 1030-1033, 2008.
93. N. Pipitone, A. Versari, and C. Salvarani, "Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update," Rheumatology, vol. 47, no. 4, pp. 403-408, 2008.
94. F. Tatò and U. Hofmann, "Giant cell arteritis: a systemic vascular disease," Vascular Medicine, vol. 13, no. 2, pp. 127-140, 2008.
95. J. Meller, F. Strutz, U. Siefer et al., "Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI," European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 5, pp. 730-736, 2003.
96. A. Cliford, S. Burrell, and J. G. Hanly, "Positron emission tomography/computed tomography for the diagnosis and assessment of giant cell arteritis: when to consider it and why," Journal of Rheumatology, vol. 39, no. 10, pp. 1909-1911, 2012.
97. G. Tegler, K. Ericson, J. Sörensen, M. Björck, and A. Wanhainen, "Infammation in the walls of asymptomatic abdominal aortic aneurysms is not associated with increased metabolic activity detectable by 18-fuorodeoxglucose positron-emission tomography," Journal of Vascular Surgery, vol. 56, no. 3, pp. 802-807, 2012.
98. F. L. Besson, J. Parienti, B. Bienvenu et al., "Diagnostic performance of 18F-fuorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis," European Journal of Nuclear Medicine and Molecular Imaging, vol. 38, no. 9, pp. 1764-1772, 2011.
99. R. A. Luqmani, "Treat-to-target in vasculitis: Is this a sensible approach?" Clinical and Experimental Rheumatology, vol. 30, supplement 73, no. 4, pp. S149-S153, 2012.
100. D. Blockmans, L. de Ceuninck, S. Vanderschueren, D. Knockaert, L. Mortelmans, and H. Bobbaers, "Repetitive 18-fuorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients," Rheumatology, vol. 46, no. 4, pp. 672-677, 2007.
101. M. Iwabu, Y. Yamamoto, H. Dobashi, T. Kameda, K. Kittaka, and Y. Nishiyama, "F-18 FDG PET fndings of takayasu arteritis before and afer immunosuppressive therapy," Clinical Nuclear Medicine, vol. 33, no. 12, pp. 872-873, 2008.
102. H. Otsuka, N. Morita, K. Yamashita, and H. Nishitani, "FDG-PET/CT for diagnosis and follow-up of vasculitis," The Journal of Medical Investigation, vol. 54, no. 3-4, pp. 345-349, 2007.
103. A. Daumas, P. Rossi, F. Bernard-Guervilly et al., "Clinical, laboratory, radiological features, and outcome in 26 patients with aortic involvement amongst a case series of 63 patients with giant cell arteritis," Revue de Medecine Interne, vol. 35, no. 1, pp. 4-15, 2014.
104. K. Raza, D. Karokis, and G. D. Kitas, "Cogan's syndrome with Takay as u 'sarteritis," British Journal of Rheumatology, vol. 37, no. 4, pp. 369-372, 1998.
105. A. C. Ho, M. I. Roat, A. Venbrux, and D. B. Hellmann, "Cogan's syndrome with refractory abdominal aortitis and mesenteric vasculitis," Journal of Rheumatology, vol. 26, no. 6, pp. 1404-1407, 1999.
106. M. Covelli, G. Lapadula, and V. Pipitone, "Cogan's syndrome: unsuccessful outcome with early combination therapy," Clinical and Experimental Rheumatology, vol. 17, no. 4, pp. 479-483, 1999.
107. J. K. Rao, N. B. Allen, and T. Pincus, "Limitations of the 1990 American College of Rheumatology classifcation criteria in the diagnosis of vasculitis," Annals of Internal Medicine, vol. 129, no. 5, pp. 345-352, 1998.
108. I. Zerizer, K. Tan, S. Khan et al., "Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis," European Journal of Radiology, vol. 73, no. 3, pp. 504-509, 2010.
109. H. Balink, P. M. Houtman, and H. J. Verberne, "Reassessing classifcation criteria for Takayasu arteritis: comment on the article by Lee et al," Arthritis and Rheumatism, vol. 64, no. 11, pp. 3818-3819, 2012.
110. Q. Liu, Z. Chang, and M. Qin, "Diagnosis of a 65-year-old male patient with Takayasu's arteritis by 18F-FDG PET/CT," Rheumatology International, vol. 31, no. 3, pp. 391-394, 2011.
111. D. Blockmans, T. Bley, and W. Schmidt, "Imaging for large-vessel vasculitis," Current Opinion in Rheumatology, vol. 21, no. 1, pp. 19-28, 2009.